SGLT inhibitors for people with type 1 diabetes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SGLT inhibitors for people with type 1 diabetes

Published:2019-05 Issue:3 Volume:36 Page:91-96
ISSN:2047-2897
Container-title:Practical Diabetes
language:en
Short-container-title:Pract Diab

Author:

Llano Andrea¹,McKay Gerry¹,Fisher Miles¹

Affiliation:

1. Glasgow Royal Infirmary Glasgow UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pdi.2222

Reference45 articles.

1. Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010

2. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison

3. Scottish Diabetes Data Group. Scottish Diabetes Survey 2017.2017.

4. NICE. NICE guideline [NG17]. Type 1 diabetes in adults: diagnosis and management. NICE 2015.

5. SIGN.ScottishIntercollegiate Guidelines Network (116): Management of diabetes: A national clinical guideline.2010.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Late-Onset Euglycemic Diabetic Ketoacidosis in a Patient With Massive Stroke Requiring Decompressive Craniectomy: A Case Report;Cureus;2021-10-09

2. Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: a meta-analysis of randomized controlled trials;Current Issues in Pharmacy and Medical Sciences;2021-09-01

3. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital;Canadian Journal of Diabetes;2021-04

4. A systematic review and dose-response meta-analysis on the efficacy of dapagliflozin in patients with type 1 diabetes mellitus;Pharmacological Research;2021-03

5. To the question of the building information modeling technologies transition to a new development level;E3S Web of Conferences;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3